Document is current
Any future updates will be listed below
-
Authors
Du, Z.
Bas-Cristóbal Menéndez, A.
Urban, M.
Hartley, A.
Ratsma, D.
Koedam, M.
van den Bosch, T. P.P.
Clahsen-van Groningen, M.
Gribnau, J.
Mulder, J.
Reinders, M. E.J.
Baan, C. C.
van der Eerden, B.
Harbottle, R. P.
Hoogduijn, Martin J. https://orcid.org/0000-0002-0217-8254
- License Information
-
More Information
Article History
Received: 2 December 2024
Accepted: 19 March 2025
First Online: 12 April 2025
Declarations
:
: iPSC were generated from human donors as part of the project ‘Creation of disease model systems to understand and correct genetic diseases through gene or other therapy using iPS cell derived from somatic cells: IPSC protocol Rotterdam’ approved by the Erasmus MC Medical Ethical Committee under approval number MEC-2017-248, which was published 29th March 2018 and last updated 15th April 2024.
: Not applicable.
: The authors have no financial or personal relationships with other people or organizations that could inappropriately influence (bias) their work.
: The animal studies were part of the project ‘Regenerative and immunomodulatory therapies to improve the outcome of kidney transplantation’, which received approval of the Dutch central committee animal experiments on 22nd Sept 2022 under license number AVD101002016635.
: The authors declare that they have not use AI-generated work in this manuscript.
